Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029521749> ?p ?o ?g. }
- W2029521749 endingPage "2627" @default.
- W2029521749 startingPage "2618" @default.
- W2029521749 abstract "Safety concerns regarding severe cardiovascular events associated with the use of selective cyclooxygenase-2 (COX-2) inhibitors resulted in the market withdrawal of rofecoxib in September 2004.Using Taiwan's National Health Insurance 2003-;2004 claims database, this population-based retrospective cohort study assessed changes in physicians' practice of prescribing a COX-2 inhibitor after market withdrawal of rofecoxib.Patients with rheumatoid arthritis (RA) or osteoarthritis (OA) who were chronic users of COX-2 inhibitors before market withdrawal of rofecoxib were identified. Eligible chronic users of COX-2 inhibitors were patients who received >or=3 consecutive prescriptions for celecoxib or rofecoxib to treat RA or OA between April 1 and September 30, 2004. The main outcome evaluated in this study was the volume of celecoxib prescribing for each patient by his or her prescribing physician at the first postwithdrawal outpatient visit related to RA or OA. For each matched physician, we calculated the prescribing practice indexes before and after the withdrawal of rofecoxib to assess changes in prescribing practice. A higher value of the index represented less potential that patients with a history of cardiovascular events who were seen by a physician received a prescription for a COX-2 inhibitor. A 2-stage model analysis was used to assess changes, in physicians' prescribing practice after rofecoxib's withdrawal, in the volume of prescribing a COX-2 inhibitor for each matched patient by his or her prescribing physician.Of the chronic users of COX-2 inhibitors identified, 13,101 were taking celecoxib and 8763 were taking rofecoxib before rofecoxib was withdrawn from the market. Concerns about safety after the mar- ket withdrawal of rofecoxib reduced physicians' volume of prescribing a COX-2 inhibitor, particularly in patients who had previously received rofecoxib. After rofecoxib's withdrawal, 72.50% of previous rofecoxib users (n = 6353) and 49.50% of previous celecoxib users (n = 6485) stopped taking COX-2 inhibitors. Only 27.50% of the rofecoxib users (n = 2410) were switched to celecoxib after rofecoxib's withdrawal. Overall, physicians' prescribing practice for celecoxib increased, from baseline to 3 months after rofecoxib's withdrawal, from 0.66 to 0.79 for academic medical center physicians, 0.71 to 0.82 for metropolitan hospital physicians, 0.77 to 0.88 for local community hospital physicians, and 0.86 to 0.92 for primary care clinic physicians. After controlling for patients' demographics, the linear regression analysis revealed that changes in physicians' prescribing practice after the withdrawal of rofecoxib affected the volume of prescribing a COX-2 inhibitor (P < 0.001).The volume of celecoxib prescribing was greatly reduced after rofecoxib was withdrawn from the market. Physicians' prescribing practice for COX-2 inhibitors significantly changed after the withdrawal, and it had a significant impact on the postwithdrawal volume of celecoxib prescribing." @default.
- W2029521749 created "2016-06-24" @default.
- W2029521749 creator A5007848141 @default.
- W2029521749 creator A5038285208 @default.
- W2029521749 creator A5063414665 @default.
- W2029521749 date "2009-11-01" @default.
- W2029521749 modified "2023-10-04" @default.
- W2029521749 title "Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan" @default.
- W2029521749 cites W1492526704 @default.
- W2029521749 cites W1672133618 @default.
- W2029521749 cites W1976327016 @default.
- W2029521749 cites W1990821235 @default.
- W2029521749 cites W2001162433 @default.
- W2029521749 cites W2008225822 @default.
- W2029521749 cites W2009069000 @default.
- W2029521749 cites W2012801178 @default.
- W2029521749 cites W2012899110 @default.
- W2029521749 cites W2021041600 @default.
- W2029521749 cites W2022097092 @default.
- W2029521749 cites W2037619899 @default.
- W2029521749 cites W2041025142 @default.
- W2029521749 cites W2053696910 @default.
- W2029521749 cites W2080867349 @default.
- W2029521749 cites W2119935630 @default.
- W2029521749 cites W2126251812 @default.
- W2029521749 cites W2136555831 @default.
- W2029521749 cites W2148359829 @default.
- W2029521749 cites W2158131645 @default.
- W2029521749 cites W2158968701 @default.
- W2029521749 cites W2169603070 @default.
- W2029521749 doi "https://doi.org/10.1016/j.clinthera.2009.11.022" @default.
- W2029521749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20110006" @default.
- W2029521749 hasPublicationYear "2009" @default.
- W2029521749 type Work @default.
- W2029521749 sameAs 2029521749 @default.
- W2029521749 citedByCount "20" @default.
- W2029521749 countsByYear W20295217492012 @default.
- W2029521749 countsByYear W20295217492013 @default.
- W2029521749 countsByYear W20295217492014 @default.
- W2029521749 countsByYear W20295217492015 @default.
- W2029521749 countsByYear W20295217492016 @default.
- W2029521749 countsByYear W20295217492017 @default.
- W2029521749 countsByYear W20295217492019 @default.
- W2029521749 countsByYear W20295217492022 @default.
- W2029521749 countsByYear W20295217492023 @default.
- W2029521749 crossrefType "journal-article" @default.
- W2029521749 hasAuthorship W2029521749A5007848141 @default.
- W2029521749 hasAuthorship W2029521749A5038285208 @default.
- W2029521749 hasAuthorship W2029521749A5063414665 @default.
- W2029521749 hasConcept C126322002 @default.
- W2029521749 hasConcept C167135981 @default.
- W2029521749 hasConcept C181199279 @default.
- W2029521749 hasConcept C185592680 @default.
- W2029521749 hasConcept C23276603 @default.
- W2029521749 hasConcept C2426938 @default.
- W2029521749 hasConcept C2776467144 @default.
- W2029521749 hasConcept C2777575956 @default.
- W2029521749 hasConcept C2778582115 @default.
- W2029521749 hasConcept C2779689624 @default.
- W2029521749 hasConcept C2908647359 @default.
- W2029521749 hasConcept C50382708 @default.
- W2029521749 hasConcept C55493867 @default.
- W2029521749 hasConcept C71924100 @default.
- W2029521749 hasConcept C98274493 @default.
- W2029521749 hasConcept C99454951 @default.
- W2029521749 hasConceptScore W2029521749C126322002 @default.
- W2029521749 hasConceptScore W2029521749C167135981 @default.
- W2029521749 hasConceptScore W2029521749C181199279 @default.
- W2029521749 hasConceptScore W2029521749C185592680 @default.
- W2029521749 hasConceptScore W2029521749C23276603 @default.
- W2029521749 hasConceptScore W2029521749C2426938 @default.
- W2029521749 hasConceptScore W2029521749C2776467144 @default.
- W2029521749 hasConceptScore W2029521749C2777575956 @default.
- W2029521749 hasConceptScore W2029521749C2778582115 @default.
- W2029521749 hasConceptScore W2029521749C2779689624 @default.
- W2029521749 hasConceptScore W2029521749C2908647359 @default.
- W2029521749 hasConceptScore W2029521749C50382708 @default.
- W2029521749 hasConceptScore W2029521749C55493867 @default.
- W2029521749 hasConceptScore W2029521749C71924100 @default.
- W2029521749 hasConceptScore W2029521749C98274493 @default.
- W2029521749 hasConceptScore W2029521749C99454951 @default.
- W2029521749 hasFunder F4320311687 @default.
- W2029521749 hasIssue "11" @default.
- W2029521749 hasLocation W20295217491 @default.
- W2029521749 hasLocation W20295217492 @default.
- W2029521749 hasOpenAccess W2029521749 @default.
- W2029521749 hasPrimaryLocation W20295217491 @default.
- W2029521749 hasRelatedWork W1972941389 @default.
- W2029521749 hasRelatedWork W2008225822 @default.
- W2029521749 hasRelatedWork W2090531910 @default.
- W2029521749 hasRelatedWork W2094903599 @default.
- W2029521749 hasRelatedWork W2110934108 @default.
- W2029521749 hasRelatedWork W2122912401 @default.
- W2029521749 hasRelatedWork W2125731916 @default.
- W2029521749 hasRelatedWork W2170824629 @default.
- W2029521749 hasRelatedWork W2172248509 @default.
- W2029521749 hasRelatedWork W2342006492 @default.
- W2029521749 hasVolume "31" @default.